Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies.
April W ArmstrongKristian ReichPeter FoleyChenglong HanMichael SongYaung-Kaung ShenYin YouKim A PappPublished in: American journal of clinical dermatology (2019)
NCT02207231 and NCT02207244.